NandroRapid Vial is the brand name for the compound Nandrolone phenyl propionate and it is manufactured by Alpha Pharma Healthcare. It is an extremely fast acting steroid with very short half-life. You have to take daily injections for the steroid’s level to remain stable in the blood. Due to short half-life, it does not stay in the body for longer period of time, therefore, tested athletes and bodybuilders prefer this steroid. Its anabolic activity is very strong but, the androgenic activity is mild. so it provides great muscle mass and strength. So it provides great muscle mass and strength. It also promotes fat loss in the body and assists you in achieving greater muscles and endurance. In medical conditions, it is used to treat different diseases like muscle wasting disease, HIV, AIDS, cancer, breast cancer, and osteoporosis.
NandroRapid Vial can be used for both bulking and cutting cycle. You just need to adjust the diet and stack it with proper steroid. For the bulking purpose, you’ll stack NandroRapid vial with testosterone. For the cutting cycle, you have the alternative of stacking it with either winstrol or Durabolin. Older users or users who are sensitive to steroids can use this with Cabaser or Dostinex.
Due to higher anabolic activity, NandroRapid vial can likely to convert into estrogen promoting the estrogenic side effects. These side effects include retention of water and gynecomastia. In order to avoid these side effects, you should take anti-estrogens like Nolvadex or Clomid. There are some androgenic side effects also which include acne, oily skin and aggressive nature. Some users have also reported decrease in their libido. To prevent thin issue, you should take smaller dose of Proviron in your cycle. It also suppresses natural testosterone production in the body, so you should take a post cycle therapy.
The common dose of NandroRapid vial for men is 400mg to 600mg in week and cycle period for eight to twelve weeks. The suggested dose for ladies is 50mg to 100mg per week.
There are no reviews yet.